| Current Price | $45.88 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $44.93 | P/E Ratio | 0.00 |
| Prev. Close | $45.88 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $44.10 - $46.43 | Volume | 1,413,152 |
| 52-Wk Range | $10.90 - $146.16 | Avg. Daily Vol. | 3,259,086 |
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease.
| Current Price | $45.88 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $44.93 | P/E Ratio | 0.00 |
| Prev. Close | $45.88 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $44.10 - $46.43 | Volume | 1,413,152 |
| 52-Wk Range | $10.90 - $146.16 | Avg. Daily Vol. | 3,259,086 |
The best Bull and Bear pitches based on recency and number of recommendations.
Cassava Sciences shares are trading higher after the company was informed by Neuroscience journal that there was no evidence to support data manipulation claims in a 2005 company-authored paper.
Read the most recent pitches from players about SAVA.
Recs
kmhjv3rt
(< 20)
Submitted: 12/21/2021 10:49:03 AM :
Start Price:
$41.31
NASDAQ:SAVA Score:
+9.58
Cassava Sciences shares are trading higher after the company was informed by Neuroscience journal that there was no evidence to support data manipulation claims in a 2005 company-authored paper.
Recs
TMFjimhalley
(< 20)
Submitted: 7/12/2021 6:46:55 PM :
Start Price:
$100.15
NASDAQ:SAVA Score:
-60.61
The potential for growth in Alzheimer's drugs is huge as our population ages. Cassava has a diagnostic blood test for Alzheimer's in the works and a therapy to treat the disease also in trials.
Recs
naughtyguy
(37.23)
Submitted: 3/20/2021 3:39:38 PM :
Start Price:
$57.03
NASDAQ:SAVA Score:
+38.51
This is WAY overbought!
Find the members with the highest scoring picks in SAVA.
medeaschild (65.74) Score: +5,848.79
The Score Leader is the player with the highest score across all their picks in SAVA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| medeaschild | 65.74 | 12/26/2018 |
|
NS | $0.76 | +5,945.73% | +96.95% | +5,848.79 | 0 Comment | |
| SmallCapSurfer2 | 92.13 | 10/13/2016 |
|
3M | $5.32 | +764.47% | +119.05% | +645.42 | 0 Comment | |
| capptten | < 20 | 12/1/2020 |
|
3M | $7.66 | +500.39% | +27.13% | +473.26 | 1 Comment | |
| foolrrrrrrrrrr | 34.31 | 11/13/2008 |
|
1Y | $37.61 | +22.29% | +464.22% | +441.93 | 0 Comment | |
| marcet | 74.62 | 3/2/2009 |
|
3W | $18.82 | +144.31% | +552.21% | +407.90 | 0 Comment | |
| Dennyf10 | 63.11 |
|
|
1Y | $35.72 | +28.73% | +420.86% | +392.12 | 0 Comment | |
| jornoski | 31.68 | 9/21/2020 |
|
5Y | $9.45 | +386.67% | +42.69% | +343.98 | 0 Comment | |
| OklaBoston | 62.33 | 9/21/2020 |
|
3Y | $9.45 | +386.67% | +42.69% | +343.98 | 1 Comment | |
| hackerbobZ | < 20 | 3/23/2009 |
|
5Y | $17.65 | +160.53% | +496.39% | +335.86 | 0 Comment | |
| clangmead | 51.51 | 1/19/2021 |
|
5Y | $10.38 | +343.06% | +22.84% | +320.23 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
